# AbbVie Q3 2026 Earnings Preview

> Wall Street expects AbbVie to beat earnings estimates with $3.78 per share on October 30.
- Title: AbbVie Q3 2026 Earnings Preview | Shortify
- Summary: Wall Street expects AbbVie to beat earnings estimates with $3.78 per share on October 30. AbbVie reports Q3 2026 earnings on October 30 with $3.78 per share…
- Keywords: abbvie, eps, q3 2026, revenue, earnings, analysts, 2026, Preview, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/abbvie-abbv-q3-2026-preview-eps-est-3-78-reports-october-30
- Author: AlphaStreet Newsdesk
- Published: 2026-10-26T11:29:46+00:00
- Read time: 1 min
- Topics: abbvie, eps, q3 2026, revenue, earnings, analysts
## Wall Street Expectations
Wall Street expects AbbVie to deliver strong growth in Q3 2026 results on October 30.
## Consensus Estimates
21 analysts estimate $3.78 per share on $17.35B revenue for Q3 2026 results.
## Recent Estimate Revisions
Consensus EPS estimate dropped 1.6% over 30 days from $3.84 to $3.78.
## Year-Over-Year Growth
Earnings grew 103.2% year-over-year to $3.78 from $1.86 in Q3 2025.
## What to Watch
Focus on management's explanation for improved net profitability versus 1.2% margin last year.
## Key takeaway

AbbVie reports Q3 2026 earnings on October 30 with $3.78 per share, a 103.2% year-over-year earnings growth.